Assignee
DABUR RES FOUNDATION
US27 patents
Top patents by PatentIndex Score
US6322817B1Nov 27, 2001
Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof
DABUR RES FOUNDATION103 citations96
US6365191B1Apr 2, 2002
Formulations of paclitaxel, its derivatives or its analogs entrapped into nanoparticles of polymeric micelles, process for preparing same and the use thereof
DABUR RES FOUNDATION68 citations93
US6632832B1Oct 14, 2003
Anti-cancer activity of carvedilol and its isomers
DABUR RES FOUNDATION25 citations92
US7094755B2Aug 22, 2006
Vasoactive intestinal peptide analogs
DABUR RES FOUNDATION31 citations90
US6403816B1Jun 11, 2002
Betulinic acid derivatives having antiangiogenic activity, processes for producing such derivatives and their use for treating tumor associated angiogenesis
DABUR RES FOUNDATION33 citations90
US6395771B1May 28, 2002
Paclitaxel derivatives for the treatment of cancer
DABUR RES FOUNDATION21 citations89
US6670345B1Dec 30, 2003
Betulinic acid derivatives for inhabiting cancer growth and process for the manufacture of betulinic acid
DABUR RES FOUNDATION27 citations88
US6136316AOct 24, 2000
Hepatoprotective compositions and composition for treatment of conditions related to hepatitis B and E infection
DABUR RES FOUNDATION53 citations87
US6228850B1May 8, 2001
Antiangiogenic activity of betulinic acid and its derivatives
DABUR RES FOUNDATION20 citations82
US6264998B1Jul 24, 2001
Extracting betulinic acid from Ziziphus jujuba
DABUR RES FOUNDATION15 citations76
US6596692B1Jul 22, 2003
Substance P analogs for the treatment of cancer
DABUR RES FOUNDATION8 citations73
US6455077B2Sep 24, 2002
Herbal composition and method of manufacturing such composition for the management of gynecological disorders
DABUR RES FOUNDATION16 citations73
US6828304B1Dec 7, 2004
Peptides for treatment of cancer
DABUR RES FOUNDATION10 citations72
US6316414B1Nov 13, 2001
Somatostatin analogs for the treatment of cancer
DABUR RES FOUNDATION13 citations72
US6489297B1Dec 3, 2002
Vasoactive intestinal peptide analogs
DABUR RES FOUNDATION12 citations71
US6613793B2Sep 2, 2003
Anticancer activity of imino acid conjugates or methylglyoxal
DABUR RES FOUNDATION11 citations70
US6608174B1Aug 19, 2003
Radiolabeled vasoactive intestinal peptide analogs for diagnosis and radiotherapy
DABUR RES FOUNDATION11 citations66
US6214814B1Apr 10, 2001
Use of betulinic acid derivatives for inhibiting cancer growth
DABUR RES FOUNDATION8 citations65
US6596755B2Jul 22, 2003
Oral formulation of methylglyoxal and its imino acid conjugates for human use
DABUR RES FOUNDATION5 citations62
US7173006B2Feb 6, 2007
Drug comprising synthetic peptide analogs for the treatment of cancer
DABUR RES FOUNDATION3 citations61
US6656970B2Dec 2, 2003
Method and compositions for solubilization of pentacyclic triterpenes
DABUR RES FOUNDATION2 citations60
US7060678B2Jun 13, 2006
Peptides comprising furanoid sugar amino acids for the treatment of cancer
DABUR RES FOUNDATION3 citations58
US6989371B1Jan 24, 2006
Bombesin analogs for treatment of cancer
DABUR RES FOUNDATION1 citations51
US6949513B2Sep 27, 2005
Polypeptides of covalently linked synthetic bioactive peptide analog(s) for treatment of cancer
DABUR RES FOUNDATION0 citations51
US6599541B1Jul 29, 2003
Composition for treatment of drug resistant bacterial infections and a method of treating drug resistant bacterial infections
DABUR RES FOUNDATION5 citations50
US7179937B2Feb 20, 2007
Cyclopentenone derivatives for cancer therapy
DABUR RES FOUNDATION0 citations30
US6949557B2Sep 27, 2005
Hydroanthracene based compounds as anticancer agents
DABUR RES FOUNDATION0 citations28